Evidence map›Paper›PMID 36312981›Full record

ArticleFrontiers in microbiology2022

Identification of an ergosterol derivative with anti-melanoma effect from the sponge-derived fungus

Tong Xia, Hui Lei, Jianv Wang, Yijing He, Hailan Wang, Lanyang Gao, Tingting Qi, Xia Xiong, Li Liu, Yongxia Zhu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tong XiaDepartment of Dermatology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Hui LeiSchool of Pharmacy, Southwest Medical University, Luzhou, China.
Jianv WangDepartment of Dermatology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Yijing HeDepartment of Science and Technology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Hailan WangSchool of Public Health, Southwest Medical University, Luzhou, China.
Lanyang GaoDepartment of Science and Technology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Tingting QiDepartment of Clinical Pharmacy, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Xia XiongDepartment of Dermatology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Li LiuDepartment of Dermatology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Yongxia ZhuDepartment of Clinical Pharmacy, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is difficult to treat malignant melanoma because of its high malignancy. New and effective therapies for treating malignant melanoma are urgently needed. Ergosterols are known for specific biological activities and have received widespread attention in cancer therapy. Here,

Indexed as

antitumorergosterolmelanomamitochondrial apoptosisOBSCN

Identifiers

PMID36312981
PMCPMC9608767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.